NumFin

Relief Therapeutics Holding AG

Sümbol: 0QKQ.L

LSE

1.2

CHF

Turuhind täna

  • -0.1533

    P/E suhe

  • -0.0017

    PEG suhe

  • 14.91M

    MRK Cap

  • 0.00%

    DIV tootlus

Relief Therapeutics Holding AG (0QKQ-L) Finantsaruanded

Download
AastaneQuarterly
LineaarneLog
Diagrammil näete Relief Therapeutics Holding AG (0QKQ.L) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist NaN M, mis on NaN % gowth. Kogu perioodi keskmine brutokasum on NaN M, mis on NaN %. Keskmine brutokasumi suhtarv on NaN %. Ettevõtte eelmise aasta tulemuse puhaskasv on NaN %, mis on võrdne NaN % % keskmiselt kogu ettevõtte ajaloo jooksul.,

AastaneQuarterly
10Y20Y30Y40Y

Bilanss

Sukeldudes Relief Therapeutics Holding AG fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja . Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus NaN. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud NaN aruandlusvaluutas. Selle aspekti aastane muutus on NaN%.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015

balance-sheet.row.cash-and-short-term-investments

014.619.244.8
43.2
0.1
0.3
0.1
0.4
0

balance-sheet.row.short-term-investments

0000
0.2
0
0
0
0
0

balance-sheet.row.net-receivables

02.82.32.7
0.1
0.1
0
0
0
0.2

balance-sheet.row.inventory

00.60.20.4
0
0
0
0
0
0

balance-sheet.row.other-current-assets

00.40.97.1
3.6
0
0.1
0
0.2
-0.2

balance-sheet.row.total-current-assets

018.322.655
46.9
0.3
0.4
0.2
0.6
0

balance-sheet.row.property-plant-equipment-net

032.72.5
0
0
0
0
0
0

balance-sheet.row.goodwill

00.578.7
0
0
0
0
0
18.8

balance-sheet.row.intangible-assets

054.4162.9192.3
30.8
19.6
35.2
30.8
30.8
0

balance-sheet.row.goodwill-and-intangible-assets

054.4169.9201
30.8
19.6
35.2
30.8
30.8
18.8

balance-sheet.row.long-term-investments

053.9-7-8.7
0.4
0
0
0
0
0

balance-sheet.row.tax-assets

00.60.51.7
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

0-53.80.10.1
0
-19.6
-35.2
-30.8
-30.8
-18.8

balance-sheet.row.total-non-current-assets

058.1166.2196.6
31.2
19.6
35.2
30.8
30.8
18.8

balance-sheet.row.other-assets

0000
0
0
0
0
0
-18.8

balance-sheet.row.total-assets

076.4188.8251.6
78
19.9
35.6
31
31.4
0

balance-sheet.row.account-payables

011.61.7
1.4
0.3
0.1
0.5
0.4
0.4

balance-sheet.row.short-term-debt

02.22.11.7
0.9
1.7
1.1
1
0.9
0

balance-sheet.row.tax-payables

000.30.5
0.4
0
0
0
0
0

balance-sheet.row.long-term-debt-total

0000.4
0
0
0
0
0
0

Deferred Revenue Non Current

02.12.22.2
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-

balance-sheet.row.other-current-liab

03.66.215.9
6.3
0.8
0.7
0.5
0.4
-0.3

balance-sheet.row.total-non-current-liabilities

017.332.750.4
4.3
2.7
12.3
8
7.5
0.7

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
-0.7

balance-sheet.row.capital-lease-obligations

02.12.22.2
0
0
0
0
0
0

balance-sheet.row.total-liab

024.243.470.1
11
5.6
14.3
10
9.2
0.1

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0

balance-sheet.row.common-stock

056.256.244.1
32.5
21.1
20.9
20.1
19.5
6.5

balance-sheet.row.retained-earnings

0-218.3-119.6-69.8
-35.2
-27.5
-20.5
-20.1
-17.8
-0.2

balance-sheet.row.accumulated-other-comprehensive-income-loss

06.25.32.6
1.2
0.2
0.2
0.2
0.1
-6.3

balance-sheet.row.other-total-stockholders-equity

0208.2203.6204.5
68.5
20.5
20.7
20.8
20.5
-0.1

balance-sheet.row.total-stockholders-equity

052.2145.4181.5
67
14.3
21.3
20.9
22.2
-0.1

balance-sheet.row.total-liabilities-and-stockholders-equity

076.4188.8251.6
78
19.9
35.6
31
31.4
0

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0

balance-sheet.row.total-equity

052.2145.4181.5
67
14.3
21.3
20.9
22.2
-0.1

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-

Total Investments

053.9-7-8.7
0.4
0
0
0
0
0

balance-sheet.row.total-debt

04.34.34.3
0.9
1.7
1.1
1
0.9
0

balance-sheet.row.net-debt

0-10.2-14.9-40.5
-42.3
1.6
0.8
0.9
0.5
0

Rahavoogude aruanne

Relief Therapeutics Holding AG finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab NaN nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides NaN, mis tähistab NaN erinevust võrreldes eelmise aastaga. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli NaN. See on NaN nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte NaN, NaN, NaN, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid NaN, kusjuures erinevus võrreldes eelmise aastaga oli NaN. Lisaks eraldas ettevõte NaN aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui NaN, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln

USD
Growth
TTM20222021202020192018201720162015

cash-flows.row.net-income

0-50.8-34.7-7.8
-7.5
-0.4
-2.9
-16.8
-0.1

cash-flows.row.depreciation-and-amortization

03.920.1
0
0
0
0
0

cash-flows.row.deferred-income-tax

0-3.5-0.81.6
-4.7
0.1
1
-0.6
0

cash-flows.row.stock-based-compensation

02.21.11
0.2
0
0.1
0.4
0

cash-flows.row.change-in-working-capital

05.6-5.20
0
-0.2
0
0.1
0.1

cash-flows.row.account-receivables

00-0.20
0
0
0
0.1
1.9

cash-flows.row.inventory

00.2-0.10
0
0
-0.4
0.6
-0.7

cash-flows.row.account-payables

0-0.1-0.81.2
0.2
-0.4
0.1
-0.3
-1.1

cash-flows.row.other-working-capital

05.5-4.1-1.2
-0.2
0.2
-0.1
0.3
0

cash-flows.row.other-non-cash-items

018.61.9-13.1
11.2
-0.2
0.7
13.4
0

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-0.5-13.70
0
0
0
0
-0.5

cash-flows.row.acquisitions-net

0-7.9-16.70
0
0
0
0.1
0

cash-flows.row.purchases-of-investments

0000
0
0
0
-0.1
0

cash-flows.row.sales-maturities-of-investments

00.50.13.3
0
0
0
0
0

cash-flows.row.other-investing-activites

000-0.2
0
0
0
0
0.5

cash-flows.row.net-cash-used-for-investing-activites

0-8-30.33
0
0
0
0.1
-0.5

cash-flows.row.debt-repayment

0-0.1-5.6-0.5
-0.6
0
0
0
0

cash-flows.row.common-stock-issued

07.176.158.3
0
0.7
0.9
2.8
0

cash-flows.row.common-stock-repurchased

0-0.2-2.8-0.6
0
0
0
0
0

cash-flows.row.dividends-paid

0-6.8-67.7-58.2
0
0
0
0
0

cash-flows.row.other-financing-activites

06.467.758.2
0.6
0
0
0.3
0

cash-flows.row.net-cash-used-provided-by-financing-activities

06.467.758.2
0.6
0.7
0.9
3.1
0

cash-flows.row.effect-of-forex-changes-on-cash

00.2-0.10.1
0
0
0
0
0

cash-flows.row.net-change-in-cash

0-25.51.643
-0.1
0.1
-0.3
0.4
0

cash-flows.row.cash-at-end-of-period

019.244.843.2
0.1
0.3
0.1
0.4
0

cash-flows.row.cash-at-beginning-of-period

044.843.20.1
0.3
0.1
0.4
0
0

cash-flows.row.operating-cash-flow

0-24.1-35.7-18.2
-0.7
-0.6
-1.2
-2.9
0

cash-flows.row.capital-expenditure

0-0.5-13.70
0
0
0
0
-0.5

cash-flows.row.free-cash-flow

0-24.6-49.4-18.2
-0.7
-0.6
-1.2
-2.9
-0.5

Kasumiaruande rida

Relief Therapeutics Holding AG tulud muutusid võrreldes eelmise perioodiga NaN%. 0QKQ.L brutokasum on teatatud NaN. Ettevõtte tegevuskulud on NaN, mille muutus võrreldes eelmise aastaga on NaN%. Kulud amortisatsioonikulud on NaN, mis on NaN% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on NaN, mis on NaN% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on NaN, mis tähendab NaN% kasvu võrreldes eelmise aastaga. Tegevustulu on NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on NaN%. Eelmise aasta puhaskasum oli NaN.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015

income-statement-row.row.total-revenue

066.13.3
0
0
0.6
0
0
0

income-statement-row.row.cost-of-revenue

016.918.111.9
0
0
0.1
0.1
0.2
0.1

income-statement-row.row.gross-profit

0-10.9-12-8.6
0
0
0.5
-0.1
-0.2
-0.1

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-

income-statement-row.row.other-expenses

0-0.2-1.3-0.7
-0.2
0
0
0
0
0

income-statement-row.row.operating-expenses

0924.526.6
19.3
0.9
0.8
1.7
16.6
0

income-statement-row.row.cost-and-expenses

025.942.638.5
19.3
0.9
0.8
1.8
16.8
0.1

income-statement-row.row.interest-income

00.100
0
0.1
0.1
0.1
0
0

income-statement-row.row.interest-expense

00.20.20.3
0.2
0.1
0.1
0.1
0.3
0.1

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-91.8-17.8-0.3
13
-11.2
0.1
-0.2
-14.9
0

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0-0.2-1.3-0.7
-0.2
0
0
0
0
0

income-statement-row.row.total-operating-expenses

0-91.8-17.8-0.3
13
-11.2
0.1
-0.2
-14.9
0

income-statement-row.row.interest-expense

00.20.20.3
0.2
0.1
0.1
0.1
0.3
0.1

income-statement-row.row.depreciation-and-amortization

03.33.92
0
0
0
0
0
0.1

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-

income-statement-row.row.operating-income

0-19.9-36.5-35.2
-19.3
-0.9
-0.5
-1.7
-1.9
-0.1

income-statement-row.row.income-before-tax

0-111.7-54.3-35.5
-6.3
-12.2
-0.4
-1.9
-16.8
-0.1

income-statement-row.row.income-tax-expense

0-13.5-3.5-0.8
1.6
-4.7
0
1
0
-0.1

income-statement-row.row.net-income

0-98.2-50.8-34.7
-7.8
-7.5
-0.4
-2.9
-16.8
-0.1
Sarnased aktsiad
Sind võib huvitada ka:
0HL9.L
Affimed N.V..
5.31 USD
LSE
0J2O.L
Halozyme Therapeutics, Inc..
43.365 USD
LSE
0T6G.L
Homology Medicines, Inc..
21.56 USD
LSE
W8A.DE
Walgreens Boots Alliance Inc.
15.964 EUR
XETRA
0UNL.L
Nektar Therapeutics.
1.65 USD
LSE
0OCQ.L
Transgene SA.
1.248 EUR
LSE
0RD1.L
Camurus AB (publ).
504.2706 SEK
LSE
0HOJ.L
Blueprint Medicines Corporation.
91.075 USD
LSE
0574.HK
Pa Shun International Holdings Limited.
0.05 HKD
HKSE
0JDB.L
Invitae Corporation.
0.0035 USD
LSE

Korduma kippuv küsimus

Mis on Relief Therapeutics Holding AG (0QKQ.L) koguvara?

Relief Therapeutics Holding AG (0QKQ.L) koguvara on 76390000.000.

Mis on ettevõtte aastane tulu?

Aastane tulu on N/A.

Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on -1.800.

Mis on ettevõtte vaba rahavoog?

Vaba rahavoog on -1.433.

Mis on ettevõtte puhaskasumimarginaal?

Puhaskasumimarginaal on -16.274.

Mis on ettevõtte kogutulu?

Kogutulu on -3.299.

Mis on Relief Therapeutics Holding AG (0QKQ.L) puhaskasum (puhaskasum)?

Puhaskasum (netotulu) on -98181000.000.

Kui suur on ettevõtte koguvõlg?

Koguvõlg on 4311000.000.

Mis on tegevuskulude arv?

Tegevuskulud on 9045000.000.

Milline on ettevõtte rahaline näitaja?

Ettevõtte raha on 0.000.